NOTCH1 and B-cell chronic lymphocytic leukemia: Activating mutations in NOTCH1, most often located in the PEST-domain or 3’-untranslated region (3’-UTR), are present in around 6-12% CLL patients at diagnosis and in 15-20% of patients with relapsed or refractory disease (131).